Literature DB >> 16282778

Velo-cardio-facial syndrome.

Robert J Shprintzen1, Anne Marie Higgins, Kevin Antshel, Wanda Fremont, Nancy Roizen, Wendy Kates.   

Abstract

PURPOSE OF REVIEW: Velo-cardio-facial syndrome has emerged from obscurity to become one of the most researched disorders this past decade. It is one of the most common genetic syndromes in humans, the most common contiguous gene syndrome in humans, the most common syndrome of cleft palate, and the most common syndrome of conotruncal heart malformations. Velo-cardio-facial syndrome has an expansive phenotype, a factor reflected in the wide range of studies that cover both clinical features and molecular genetics. In this review, we cover multiple areas of research during the past year, including psychiatric disorders, neuroimaging, and the delineation of clinical features. RECENT
FINDINGS: The identification of candidate genes for heart anomalies, mental illness, and other clinical phenotypes has been reported in the past year with a focus on TBX1 for cardiac and craniofacial phenotypes and COMT and PRODH for psychiatric disorders. The expansive phenotype of velo-cardio-facial syndrome continues to grow with new behavioral and structural anomalies reported. Treatment issues are beginning to draw attention, although most authors continue to focus on diagnostic issues.
SUMMARY: Its high population prevalence, estimated to be as common as 1:2000 has sparked a large amount of research, as has the model the syndrome serves for identifying the causes of mental illness and learning disabilities, but it is obvious that more information is needed. Intensive scrutiny of velo-cardio-facial syndrome will undoubtedly continue for many years to come with the hope that researchers will turn more of their attention to treatment and treatment outcomes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16282778     DOI: 10.1097/01.mop.0000184465.73833.0b

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  30 in total

1.  22q11.2 deletion syndrome: are motor deficits more than expected for IQ level?

Authors:  Nancy J Roizen; Anne M Higgins; Kevin M Antshel; Wanda Fremont; Robert Shprintzen; Wendy R Kates
Journal:  J Pediatr       Date:  2010-06-19       Impact factor: 4.406

Review 2.  Genetic Disorders of Parathyroid Development and Function.

Authors:  Rebecca J Gordon; Michael A Levine
Journal:  Endocrinol Metab Clin North Am       Date:  2018-10-12       Impact factor: 4.741

Review 3.  A review of neurocognitive and behavioral profiles associated with 22q11 deletion syndrome: implications for clinical evaluation and treatment.

Authors:  Opal Ousley; Kimberly Rockers; Mary Lynn Dell; Karlene Coleman; Joseph F Cubells
Journal:  Curr Psychiatry Rep       Date:  2007-04       Impact factor: 5.285

4.  Enhanced maternal origin of the 22q11.2 deletion in velocardiofacial and DiGeorge syndromes.

Authors:  Maria Delio; Tingwei Guo; Donna M McDonald-McGinn; Elaine Zackai; Sean Herman; Mark Kaminetzky; Anne Marie Higgins; Karlene Coleman; Carolyn Chow; Maria Jalbrzikowski; Maria Jarlbrzkowski; Carrie E Bearden; Alice Bailey; Anders Vangkilde; Line Olsen; Charlotte Olesen; Flemming Skovby; Thomas M Werge; Ludivine Templin; Tiffany Busa; Nicole Philip; Ann Swillen; Joris R Vermeesch; Koen Devriendt; Maude Schneider; Sophie Dahoun; Stephan Eliez; Kelly Schoch; Stephen R Hooper; Vandana Shashi; Joy Samanich; Robert Marion; Therese van Amelsvoort; Erik Boot; Petra Klaassen; Sasja N Duijff; Jacob Vorstman; Tracy Yuen; Candice Silversides; Eva Chow; Anne Bassett; Amos Frisch; Abraham Weizman; Doron Gothelf; Maria Niarchou; Marianne van den Bree; Michael J Owen; Damian Heine Suñer; Jordi Rosell Andreo; Marco Armando; Stefano Vicari; Maria Cristina Digilio; Adam Auton; Wendy R Kates; Tao Wang; Robert J Shprintzen; Beverly S Emanuel; Bernice E Morrow
Journal:  Am J Hum Genet       Date:  2013-02-28       Impact factor: 11.025

5.  The use of two different MLPA kits in 22q11.2 deletion syndrome.

Authors:  L J M Evers; J J M Engelen; L M H Houben; L M G Curfs; T A M J van Amelsvoort
Journal:  Eur J Med Genet       Date:  2016-02-24       Impact factor: 2.708

Review 6.  Immunological aspects of 22q11.2 deletion syndrome.

Authors:  A R Gennery
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

7.  Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature.

Authors:  Fabíola P Monteiro; Társis P Vieira; Ilária C Sgardioli; Miriam C Molck; Ana Paula Damiano; Josiane Souza; Isabella L Monlleó; Marshall I B Fontes; Agnes C Fett-Conte; Têmis M Félix; Gabriela F Leal; Erlane M Ribeiro; Claudio E M Banzato; Clarissa de R Dantas; Iscia Lopes-Cendes; Vera Lúcia Gil-da-Silva-Lopes
Journal:  Eur J Pediatr       Date:  2013-02-26       Impact factor: 3.183

8.  Young Adult Outcomes for Children With 22q11 Deletion Syndrome and Comorbid ADHD.

Authors:  Lea E Taylor; Wendy R Kates; Wanda Fremont; Kevin M Antshel
Journal:  J Pediatr Psychol       Date:  2018-07-01

9.  Early thyroid development requires a Tbx1-Fgf8 pathway.

Authors:  Gabriella Lania; Zhen Zhang; Tuong Huynh; Cinzia Caprio; Anne M Moon; Francesca Vitelli; Antonio Baldini
Journal:  Dev Biol       Date:  2009-01-20       Impact factor: 3.582

10.  The longitudinal course of attention deficit/hyperactivity disorder in velo-cardio-facial syndrome.

Authors:  Kevin M Antshel; Kaitlin Hendricks; Robert Shprintzen; Wanda Fremont; Anne Marie Higgins; Stephen V Faraone; Wendy R Kates
Journal:  J Pediatr       Date:  2013-01-18       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.